Edwards Lifesciences
EW
85.78
-0.70
-0.81%
Edwards Lifesciences
US · EW
#442 by market cap
Listed 1970
85.78
-0.70
-0.81%
Live - 5344 symbols - heartbeat 561s ago
· 2026-10-08 04:00
Pre-market
85.78
0.00%
After-hours
85.78
0.00%
- Market cap
- 49.44B
- P/E (TTM)i
- 49.87
- P/Bi
- 4.66
- EPSi
- 1.83
- Div yieldi
- 0.00%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on EW?
Anonymous reader poll. Unscientific, not investment advice.
About Edwards Lifesciences
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
- Founded
- 1958
- CEO
- Mr. Bernard J. Zovighian
- Employees
- 16,000
- Headquarters
- Irvine, California, United States of America
- Fiscal year end
- 12-31
- Website
- edwards.com
Company profile
- Exchange
- US
- Symbol
- EW
- Market-cap rank
- #442
- Listing date
- 1970-01-01
- Market cap
- 49.44B
- Float cap
- 49.28B
- Shares out
- 576.40M
- Float shares
- 574.49M
Sectors & themes
Quote time 2026-10-08 04:00:07 · For reference only, not investment advice and not tailored to your situation.